Next Science Revenue and Competitors

Sydney, Australia

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Next Science's estimated annual revenue is currently $17.1M per year.(i)
  • Next Science's estimated revenue per employee is $155,000

Employee Data

  • Next Science has 110 Employees.(i)
  • Next Science grew their employee count by 33% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$52.4M33828%N/AN/A
#2
$13.8M899%N/AN/A
#3
$17.1M11033%N/AN/A
#4
$17.2M11150%N/AN/A
#5
$42.2M27211%N/AN/A
#6
$8.7M5614%N/AN/A
#7
$13.6M88-14%N/AN/A
#8
$12.9M83-6%N/AN/A
#9
$16.9M1098%N/AN/A
#10
$21.2M137-4%$33.8MN/A
Add Company

Next Science pioneers innovative, proprietary technologies to address the problem of biofilm. With proven, experienced management and scientific leadership, Next Science and its partners deliver break-through solutions that see beyond the current limits imposed by powerful bacterial colonies. Next Science offers a new solution to the biofilm problem with a proprietary, non-toxic technology that disrupts the biofilm's extracellular polymeric substance (EPS) matrix and, unlike competitors, offers no known opportunity for bacterial resistance. Recent clinical studies and field evaluations have shown Next Science products advance healing, reduce the number of bacteria present, and regardless of setting, help to prevent the growth of further biofilm structures. Next Science looks to partner with companies, organizations, and research institutions that share its future-forward vision of shifting the paradigm of biofilm eradication. In particular, Next Science looks to build effective collaborations with commercials partners who excel in a number of different therapeutic areas for licensing. Please contact us for a meeting.

keywords:N/A

N/A

Total Funding

110

Number of Employees

$17.1M

Revenue (est)

33%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Next Science News

2022-04-20 - Climate change could spark the next pandemic, new study finds

The research described is supported in part by a National Science Foundation (NSF) Biology Integration Institutes (BII) grant (BII 2021909),...

2022-04-19 - Next Science - Appendix 4C - 31 March 2022

Next Science - Appendix 4C - 31 March 2022. 28 Apr 2022 08:20 AM. To view the appendix, download the attached PDF. Download this document...

2022-04-19 - Next Science : Investor Presentation - Q1 2022

This presentation has been prepared by Next Science Limited (Company) and is provided for general information purposes only. It is not a product...

2019-09-08 - Antibiotic developer Next Science emerges on top

Biotechnology start-up Next Science (ASX: NXS) has emerged as one of the top five performing stocks on the ASX with investors recognising a ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$18.7M12913%N/A
#2
$15.5M129-2%N/A
#3
$19.3M13360%N/A
#4
$75M136-9%N/A
#5
$16M14525%N/A